Clinical Trial Update: A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

The update reports completion of a Phase 2 trial evaluating the safety and effects of EMD 72000 in subjects with recurrent ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• EMD 72000

Snippet

Sponsor: EMD Serono | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED